These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Comparative study of two antihypertensive agents: guanfacine and guanethidine. Szám I; Kállay K Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):85S-87S. PubMed ID: 6994786 [TBL] [Abstract][Full Text] [Related]
5. Comparison of guanadrel and guanethidine. Hansson L; Pascual A; Julius S Clin Pharmacol Ther; 1973; 14(2):204-8. PubMed ID: 4571980 [No Abstract] [Full Text] [Related]
6. Guanethidine and bethanidine in the management of hypertension. Moser M Am Heart J; 1969 Mar; 77(3):423-6. PubMed ID: 4387977 [No Abstract] [Full Text] [Related]
7. Comparison of the antihypertensive effectiveness of guanadrel and guanethidine. Chrysant SG; Frohlich ED Curr Ther Res Clin Exp; 1976 Mar; 19(3):379-85. PubMed ID: 817868 [No Abstract] [Full Text] [Related]
8. Comparison of guanadrel and guanethidine efficacy and side effects. Malinow SH Clin Ther; 1983; 5(3):284-9. PubMed ID: 6850722 [TBL] [Abstract][Full Text] [Related]
9. ADRENALINE, NORADRENALINE AND DOPAMINE EXCRETION IN PATIENTS WITH ESSENTIAL HYPERTENSION. SERRANO PA; FIGUEROA G; TORRES M; RAMIREZDELANGEL A Am J Cardiol; 1964 Apr; 13():484-8. PubMed ID: 14136290 [No Abstract] [Full Text] [Related]
10. [Studies on hemodynamics after intravenous application of dihydralazine and guanethidine in hypertonic patients]. Juchems R; Ammerschläger G Arzneimittelforschung; 1967 May; 17(5):587-91. PubMed ID: 4873896 [No Abstract] [Full Text] [Related]
11. [Betanidine as a component of a combination therapy in severe hypertension]. Fischer U; Fritz KW Med Welt; 1969 Aug; 34():1842-6. PubMed ID: 4897687 [No Abstract] [Full Text] [Related]
12. Trial of combination of guanethidine and oxprenolol in hypertension. Pearson RM; Bending MR; Bulpitt CJ; George CF; Hole DR; Williams FM; Breckenridge AM Br Med J; 1976 Apr; 1(6015):933-6. PubMed ID: 773486 [TBL] [Abstract][Full Text] [Related]
13. [A controlled blind study of 4 antihypertensive agents (methyldopa and 3 sympatholytic agents)]. Vejlsgaard V; Christensen M; Clausen E Ugeskr Laeger; 1967 May; 129(19):635-8. PubMed ID: 4877293 [No Abstract] [Full Text] [Related]
14. Letter: Debrisoquine, guanethidine, and bethanidine in hypertension. Talbot S; O'Malley BC; Bing RH Br Med J; 1975 May; 2(5965):278. PubMed ID: 1131592 [No Abstract] [Full Text] [Related]
15. Double-blind trial of four hypotensive drugs (methyldopa and three sympatholytic agents). Vejlsgaard V; Christensen M; Clausen E Br Med J; 1967 Jun; 2(5552):598-600. PubMed ID: 6025595 [No Abstract] [Full Text] [Related]
16. The use of guanethidine and hydrochlorothiazide in the long-term treatment of essential hypertension. Brown WJ; Brown FK Curr Ther Res Clin Exp; 1975 Jun; 17(6):544-54. PubMed ID: 808377 [No Abstract] [Full Text] [Related]
17. The relative efficacy of guanethidine, methyldopa and pargyline as antihypertensive agents. Oates JA; Seligmann AW; Clark MA; Rousseau P; Lee RE N Engl J Med; 1965 Sep; 273(14):729-34. PubMed ID: 5317954 [No Abstract] [Full Text] [Related]
18. [Therapeutic combinations, side effects and interactions of antihypertensive drugs]. Angelino PF Minerva Cardioangiol; 1976 Jun; 24(6):456-64. PubMed ID: 1012494 [No Abstract] [Full Text] [Related]
19. Controlled trial of guanethidine and methyldopa in moderate hypertension. Tarpley EL Curr Ther Res Clin Exp; 1974 Nov; 16(11):1187-96. PubMed ID: 4214653 [No Abstract] [Full Text] [Related]
20. Clinical experience with bethanidine in treatment of hypertension. Bath J; Pickering D; Turner R Br Med J; 1967 Dec; 4(5578):519-21. PubMed ID: 6065986 [No Abstract] [Full Text] [Related] [Next] [New Search]